Samant
Abhay Samant, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20100127918 | Generation of Multi-satellite GPS Signals in Software - A method for testing GPS receivers may read GPS files with data for a plurality of GPS satellites, and two or more GPS satellites may be selected from that data. The method may receive parameters for a GPS receiver to be tested. The method may generate two or more GPS signals for the two or more selected GPS satellites. The method may operate on the two or more GPS signals using the received parameters for the GPS receiver to generate two or more calculated GPS signals. These two or more calculated GPS signals may be re-sampled to a common rate. The two or more re-sampled GPS signals may be added together to create a composite GPS signal. The composite GPS signal may be generated using a hardware signal generator, where the composite GPS signal used to test the GPS receiver. | 05-27-2010 |
20120026994 | Classification of Wireless LAN Signals - A system and method for classifying an input signal suspected of being a wireless LAN signal. Bursts are isolated based on an analysis of an average power signal that is derived from the input signal. A correlation-based test is performed to determine if the input signal contains a Barker code typical of DSSS transmissions. Another correlation-based test is performed to determine of the input signal contains a long training sequence typical of OFDM transmissions. The results of the two tests are used to classify the input signal as being DSSS, OFDM or neither. | 02-02-2012 |
20120027065 | Detecting the Modulation Type and/or Constellation Order of a PSK/QAM-Modulated Signal - A system and method for determining the modulation type and constellation order of an input signal given that the modulation type and constellation order are known to belong to set of possible types/orders. A computer operates on samples of the input signal to compute signal features. The computer classifies the modulation type and the constellation order by comparing each feature to one or more corresponding threshold values. The results of the comparisons are used to determine the modulation type and constellation order of the input signal from the set of possible types/orders. The classification may be performed based on a decision tree, each leaf node of the decision tree corresponding to a type/order combination, and each non-leaf node corresponding to one or more of the comparisons. The set of possible types/order may include PSK with a number of different constellation orders and QAM with a number of different constellation orders. | 02-02-2012 |
Anirudha V. Samant, Plainfield, IL US
Patent application number | Description | Published |
---|---|---|
20150311023 | METHOD TO FABRICATE PORTABLE ELECTRON SOURCE BASED ON NITROGEN INCORPORATED ULTRANANOCRYSTALLINE DIAMOND (N-UNCD) - A source cold cathode field emission array (FEA) source based on ultra-nanocrystalline diamond (UNCD) field emitters. This system was constructed as an alternative for detection of obscured objects and material. Depending on the geometry of the given situation a flat-panel source can be used in tomography, radiography, or tomosynthesis. Furthermore, the unit can be used as a portable electron or X-ray scanner or an integral part of an existing detection system. UNCD field emitters show great field emission output and can be deposited over large areas as the case with carbon nanotube “forest” (CNT) cathodes. Furthermore, UNCDs have better mechanical and thermal properties as compared to CNT tips which further extend the lifetime of UNCD based FEA. | 10-29-2015 |
Kalika Ranjan Samant, Hockessin, DE US
Patent application number | Description | Published |
---|---|---|
20100159184 | POLY-TRIMETHYLENE TEREPHTHALATE SOLID CORE FIBRILLATION-RESISTANT FILAMENT HAVING A SUBSTANTIALLY TRIANGULAR CROSS SECTION, A SPINNERET FOR PRODUCING THE FILAMENT, AND A CARPET MADE THEREFROM - In a first aspect the invention is a solid core fibrillation-resistant, synthetic polymeric filament having three substantially equal length convex sides. The sides through substantially rounded tips centered by a distance “a” from the axis of the filament. Each rounded tip has a radius substantially equal to a length “b”. Each tip lies on a circumscribed circle having a radius substantially equal to a length (a+b) and the midpoint of each side lies on an inscribed circle having a radius substantially equal to a length “c”. The filament has a denier-per-filament in the range 10<“dpf”<35; the distance “a” lies in the range 0.00025 inches (6 micrometers)<“a”<0.004 inches (102 micrometers); the distance “b” lies in the range from 0.00008 inches (2 micrometers)<“b”<0.001 inches (24 micrometers); the distance “c” lies in the range from 0.0003 inches (8 micrometers)<“c”<0.0025 inches (64 micrometers); and the modification ratio (“MR”) lies in the range from about 1.1<“MR”< about 2.0. | 06-24-2010 |
20100159186 | POLY-TRIMETHYLENE TEREPHTHALATE SOLID CORE FIBRILLATION-RESISTANT FILAMENT HAVING A SUBSTANTIALLY TRIANGULAR CROSS SECTION, A SPINNERET FOR PRODUCING THE FILAMENT, AND A CARPET MADE THEREFROM - In a first aspect the invention is a solid core fibrillation-resistant, synthetic polymeric filament having three substantially equal length convex sides. The sides through substantially rounded tips centered by a distance “a” from the axis of the filament. Each rounded tip has a radius substantially equal to a length “b”. Each tip lies on a circumscribed circle having a radius substantially equal to a length (a+b) and the midpoint of each side lies on an inscribed circle having a radius substantially equal to a length “c”. The filament has a denier-per-filament in the range 10<“dpf”<35; the distance “a” lies in the range 0.00025 inches (6 micrometers)<“a”<0.004 inches (102 micrometers); the distance “b” lies in the range from 0.00008 inches (2 micrometers)<“b”<0.001 inches (24 micrometers); the distance “c” lies in the range from 0.0003 inches (8 micrometers)<“c”<0.0025 inches (64 micrometers); and the modification ratio (“MR”) lies in the range from about 1.1<“MR”06-24-2010 | |
20110311759 | FLAME RETARDANT PERFORMANCE IN POLY (TRIMETHYLENE) TEREPHTHALATE - Poly(trimethylene terephthalate) compositions, and articles made therefrom, having improved flame retardancy are provided. The compositions can be used to make carpets that are suitable for installation where flame retardancy is desired. | 12-22-2011 |
20120128924 | RECYCLED POLY(TRIMETHYLENE TEREPHTHALATE) AND PROCESSES - The present invention relates to recycled poly(trimethylene terephthalate), and products and processes using the recycled poly(trimethylene terephthalate). | 05-24-2012 |
20130029086 | POLY-TRIMETHYLENE TEREPHTHALATE SOLID CORE FIBRILLATION-RESISTANT FILAMENT HAVING A SUBSTANTIALLY TRIANGULAR CROSS SECTION, A SPINNERET FOR PRODUCING THE FILAMENT, AND A CARPET MADE THEREFROM - In a first aspect the invention is a solid core fibrillation-resistant, synthetic polymeric filament having three substantially equal length convex sides. The sides through substantially rounded tips centered by a distance “a” from the axis of the filament. Each rounded tip has a radius substantially equal to a length “b”. Each tip lies on a circumscribed circle having a radius substantially equal to a length (a+b) and the midpoint of each side lies on an inscribed circle having a radius substantially equal to a length “c”. The filament has a denier-per-filament in the range 10<“dpf”<35; the distance “a” lies in the range 0.00025 inches (6 micrometers)<“a”<0.004 inches (102 micrometers); the distance “b” lies in the range from 0.00008 inches (2 micrometers)<“b”<0.001 inches (24 micrometers); the distance “c” lies in the range from 0.0003 inches (8 micrometers)<“c”<0.0025 inches (64 micrometers); and the modification ratio (“MR”) lies in the range from about 1.1<“MR”01-31-2013 | |
20130029152 | POLY-TRIMETHYLENE TEREPHTHALATE SOLID CORE FIBRILLATION-RESISTANT FILAMENT HAVING A SUBSTANTIALLY TRIANGULAR CROSS SECTION, A SPINNERET FOR PRODUCING THE FILAMENT, AND A CARPET MADE THEREFROM - In a first aspect the invention is a solid core fibrillation-resistant, synthetic polymeric filament having three substantially equal length convex sides. The sides through substantially rounded tips centered by a distance “a” from the axis of the filament. Each rounded tip has a radius substantially equal to a length “b”. Each tip lies on a circumscribed circle having a radius substantially equal to a length (a+b) and the midpoint of each side lies on an inscribed circle having a radius substantially equal to a length “c”. The filament has a denier-per-filament in the range 10<“dpf”<35; the distance “a” lies in the range 0.00025 inches (6 micrometers)<“a”<0.004 inches (102 micrometers); the distance “b” lies in the range from 0.00008 inches (2 micrometers)<“b”<0.001 inches (24 micrometers); the distance “c” lies in the range from 0.0003 inches (8 micrometers)<“c”<0.0025 inches (64 micrometers); and the modification ratio (“MR”) lies in the range from about 1.1<“MR”01-31-2013 | |
20130034658 | POLY-TRIMETHYLENE TEREPHTHALATE SOLID CORE FIBRILLATION-RESISTANT FILAMENT HAVING A SUBSTANTIALLY TRIANGULAR CROSS SECTION, A SPINNERET FOR PRODUCING THE FILAMENT, AND A CARPET MADE THEREFROM - In a first aspect the invention is a solid core fibrillation-resistant, synthetic polymeric filament having three substantially equal length convex sides. The sides through substantially rounded tips centered by a distance “a” from the axis of the filament. Each rounded tip has a radius substantially equal to a length “b”. Each tip lies on a circumscribed circle having a radius substantially equal to a length (a+b) and the midpoint of each side lies on an inscribed circle having a radius substantially equal to a length “c”. The filament has a denier-per-filament in the range 10<“dpf”<35; the distance “a” lies in the range 0.00025 inches (6 micrometers)<“a”<0.004 inches (102 micrometers); the distance “b” lies in the range from 0.00008 inches (2 micrometers)<“b”<0.001 inches (24 micrometers); the distance “c” lies in the range from 0.0003 inches (8 micrometers)<“c”<0.0025 inches (64 micrometers); and the modification ratio (“MR”) lies in the range from about 1.1<“MR”02-07-2013 | |
Lalita Samant, Vestavia Hills, AL US
Patent application number | Description | Published |
---|---|---|
20130224311 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - Some embodiments of the present invention relate to methods and compositions for treating cancer. More embodiments include methods and compositions for modulating the activity of the Hedgehog pathway. | 08-29-2013 |
20140364485 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - Some embodiments of the present invention relate to agents and compositions for treating cancer. More embodiments include agents and compositions for modulating the activity of the Hedgehog pathway. | 12-11-2014 |
Lalita Samant, Mobile, AL US
Patent application number | Description | Published |
---|---|---|
20130137753 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF BREAST CANCER - Embodiments of the present disclosure relate to methods and compositions for the diagnosis and treatment of breast cancer. In some embodiments, the present disclosure relates to the use of Merlin, OPN and particular microRNAs for evaluating the presence of breast cancer in a subject and for identifying therapeutic compounds. | 05-30-2013 |
20140309184 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OVARIAN CANCER - Embodiments of the present disclosure relate to methods and compositions for treating a subject with ovarian cancer. Some embodiments include treating a subject with a particular combination of chemotherapeutic agents. | 10-16-2014 |
20150252436 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER - The present invention relates to methods and compositions for diagnosing and treating cancer, such as breast cancer and skin cancer. | 09-10-2015 |
Mahesh Samant, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20120256435 | ROBOTIC DEVICE FOR SUBSTRATE TRANSFER APPLICATIONS - A device for use in the semiconductor industry includes a robotic arm whose end effector includes at least two prongs designed to hold a substrate carrier. A pushing member located between the prongs can move independently of the prongs and is configured to exert force against the substrate carrier while the prongs are retracted from the substrate carrier, after the substrate carrier has been brought to its intended position. In this manner, the position of the substrate carrier is maintained at its intended position as the prongs are retracted. Each of the prongs may include a claw or gripping member for grasping the substrate carrier. | 10-11-2012 |
Mahesh G. Samant, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20130316543 | METHOD AND APPARATUS FOR SUBSTRATE-MASK ALIGNMENT - A shadow masking device for use in the semiconductor industry includes self-aligning mechanical components that permit shadow masks to be exchanged while maintaining precise alignment with the target substrate. The misregistration between any two of the various layers in the formed structure can be kept to less than 40 microns. | 11-28-2013 |
20140266391 | CONTROLLING THE CONDUCTIVITY OF AN OXIDE BY APPLYING VOLTAGE PULSES TO AN IONIC LIQUID - Electrolyte gating with ionic liquids is a powerful tool for inducing conducting phases in correlated insulators. An archetypal correlated material is VO | 09-18-2014 |
Mahesh Govind Samant, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20110140762 | Resistive Switching in Nitrogen-doped MgO - Nitrogen-doped MgO insulating layers exhibit voltage controlled resistance states, e.g., a high resistance and a low resistance state. Patterned nano-devices on the 100 nm scale show highly reproducible switching characteristics. The voltage levels at which such devices are switched between the two resistance levels can be systematically lowered by increasing the nitrogen concentration. Similarly, the resistance of the high resistance state can be varied by varying the nitrogen concentration, and decreases by orders of magnitude by varying the nitrogen concentrations by a few percent. On the other hand, the resistance of the low resistance state is nearly insensitive to the nitrogen doping level. The resistance of single Mg | 06-16-2011 |
20130164113 | ROBOTIC DEVICE FOR SUBSTRATE TRANSFER APPLICATIONS - A device for use in the semiconductor industry includes a robotic arm whose end effector includes electromagnetic means to hold a substrate carrier. A pushing member can move independently of a flat, spatula-like portion of the device and is configured to exert force against the substrate carrier while the spatula-like portion is retracted from the substrate carrier, after the substrate carrier has been brought to its intended position. In this manner, the position of the substrate carrier is maintained at its intended position as the spatula-like portion is retracted. | 06-27-2013 |
Manoj Samant, Burlington, MA US
Patent application number | Description | Published |
---|---|---|
20130123169 | PEPTIDOMIMETIC MACROCYCLES - The present invention provides peptidomimetic macrocycles capable of modulating growth hormone levels and methods of using such macrocycles for the treatment of disease. | 05-16-2013 |
Manoj P. Samant, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140221287 | Amylin Peptides and Derivatives and Uses Thereof - There are provided polypeptide conjugates having enhanced duration of biological activity, and methods of use thereof. The polypeptide conjugates include duration enhancing moieties, including water soluble polymers, bound to the polypeptide components of defined sequence. Methods of use are provided for treatment of metabolic disorders. Methods of use are provided for treatment of an eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyper lipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. | 08-07-2014 |
20140235535 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH REDUCED IMMUNOGENICITY - Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including oral administration, and reduced immunogenicity. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including obesity and overweight, diabetes, dyslipidemia, hyperlipidemia, Alzheimer's disease, fatty liver disease, Short Bowel Syndrome, Parkinson's disease, and cardiovascular disease. | 08-21-2014 |
20140249076 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIES - Provided herein are amylin-calcitonin peptide conjugates having enhanced duration of biological activity, and methods of use thereof. The amylin-calcitonin peptide conjugates include duration enhancing moieties, such as water soluble polymers and long chain aliphatic groups, bound to the amylin-calcitonin peptide. Methods of use are provided for treatment of an eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis or osteoarthritis. | 09-04-2014 |
Manoj P. Samant, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140107019 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION - Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including oral administration. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including obesity and overweight, diabetes, dyslipidemia, hyperlipidemia, Alzheimer's disease, fatty liver disease, short bowel syndrome, Parkinson's disease, cardiovascular disease, and other and disorders of the central nervous system. | 04-17-2014 |
Manoj P. Samant, Burlington, MA US
Patent application number | Description | Published |
---|---|---|
20150111246 | SITE-SPECIFIC ENZYMATIC MODIFICATION OF EXENDINS AND ANALOGS THEREOF - There is provided inter alia a method of covalently attaching an amine derivatizing agent to a glutamine of a first polypeptide. The method includes adding an amine derivatizing agent, a transglutaminase a first polypeptide which includes a glutamine, and a co-solvent to a reaction mixture. The method further includes allowing the amine derivatizing agent to react with the glutamine of the first polypeptide in the reaction mixture to form an amide bond, thereby covalently attaching the amine derivatizing agent to the glutamine of the first polypeptide. | 04-23-2015 |
Radhika Samant, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090035815 | Synthetic Gene for Enhanced Expression in E. Coli - A novel nesiritide synthetic cDNA chimera encoding human b-type natriuretic peptide (hBNP) or nesiritide and a process for the preparation of the said novel chimera. Further, the inventors disclose the use of nesiritide synthetic cDNA chimera to obtain an expressible construct to produce mature nesiritide. Particularly, the inventors disclose an application of recombinant cloning method to prepare an ORF of a nesiritide chimeric construct, which is simultaneously codon optimized for | 02-05-2009 |
Rajan Shantaram Samant, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120263784 | EMERGENCY CONTRACEPTIVE - The present invention discloses an emergency contraceptive formulation for nasal and/or pulmonary administration comprising of levonorgestrel optionally in combination with ethylestradiol. The said formulation can be in form of solution, suspension or carrier based systems selected from microemulsion and liposomes. | 10-18-2012 |
Rajeev Samant, Mobile, AL US
Patent application number | Description | Published |
---|---|---|
20130137753 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF BREAST CANCER - Embodiments of the present disclosure relate to methods and compositions for the diagnosis and treatment of breast cancer. In some embodiments, the present disclosure relates to the use of Merlin, OPN and particular microRNAs for evaluating the presence of breast cancer in a subject and for identifying therapeutic compounds. | 05-30-2013 |
20130224311 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - Some embodiments of the present invention relate to methods and compositions for treating cancer. More embodiments include methods and compositions for modulating the activity of the Hedgehog pathway. | 08-29-2013 |
20150252436 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER - The present invention relates to methods and compositions for diagnosing and treating cancer, such as breast cancer and skin cancer. | 09-10-2015 |
Rajeev Samant, Vestavia Hills, AL US
Patent application number | Description | Published |
---|---|---|
20140364485 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - Some embodiments of the present invention relate to agents and compositions for treating cancer. More embodiments include agents and compositions for modulating the activity of the Hedgehog pathway. | 12-11-2014 |
Sanjiv Singh Samant, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20110110490 | METHOD AND APPARATUS FOR X-RAY RADIOGRAPHIC IMAGING - Embodiments of the invention relate to a method for x-ray radiography and apparatus for use in x-ray radiography. Specific embodiments can utilize a grid having a plurality of apertures therethrough with optical waveguides positioned in the apertures. The optical waveguides can incorporate a scintillating material, preferably throughout, that absorbs incident x-ray radiation and emits light that is then guided by the optical waveguide. In a specific embodiment, x-ray radiation incident on a first end of the aperture is absorbed by the scintillating material in the optical waveguide and light is emitted by the same scintillating material, a portion of which is guided by the optical waveguide to a second end of the aperture. In addition, secondary electrons created by absorption of the x-ray radiation by the scintillating material can be absorbed by the scintillating material to create more light such that a magnification effect can occur. The light exiting the second end of the aperture can then be detected. | 05-12-2011 |
Shalaka Samant, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140154742 | NOVEL EXPRESSION AND SECRETION VECTOR SYSTEMS FOR HETEROLOGOUS PROTEIN PRODUCTION IN ESCHERICHIA COLI - The present invention relates to a recombinant DNA expression/secretion system in | 06-05-2014 |
Shantanu Samant, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20120058228 | CHOCOLATE COMPOSITION - A chocolate composition and a process for the manufacture of a chocolate composition. The chocolate composition comprises cocoa butter substitute/cocoa butter equivalent in combination with whey. In particular, the composition comprises 40-70 wt % sweetener, 25-30 wt % cocoa butter substitute (CBS) and/or cocoa butter equivalent (CBE), 4-10 wt % non-fat cocoa solids, milk solids and from 0-2 wt % cocoa butter, wherein at least 80 wt % of the milk solids are constituted by whey. | 03-08-2012 |
Shantanu Krishnarao Samant, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20110256271 | Center-Filled Confection and Method - A center-filled confection has a center comprising a center composition and a shell surrounding a liquid center. The said center includes a bulk sweetener and a fat having a slip melting point of 10 to 18° C. The said shell comprises a shell composition including less than or equal to 20 weight percent total fat based on the total weight of the shell composition. | 10-20-2011 |
Urmila Chandrashekhar Samant, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20140099293 | METHOD FOR EX-VIVO SEPARATION OF APOPTOTIC CHROMATIN FRAGMENTS FROM BLOOD OR PLASMA FOR PREVENTION AND TREATMENT OF DIVERSE HUMAN DISEASES - A method of prevention/treatment of pathological consequences of DNA damage triggered by incorporation of circulating apoptotic chromatin fragments into healthy cells of individuals/patients in need therefore, said method comprising ex vivo or extra corporeal treatment of blood/plasma for removal of circulating chromatin fragments released from apoptotic cells which apoptotic chromatin fragments are capable of triggering DNA damage leading to genomic instability, senescence, apoptosis and cancerous transformation of healthy cells on being integrated into their genomes | 04-10-2014 |
Vivek Samant, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20090125245 | Methods For Rapid Forensic Analysis Of Mitochondrial DNA - The present invention provides methods for rapid forensic analysis of mitochondrial DNA by amplification of a segment of mitochondrial DNA containing restriction sites, digesting the mitochondrial DNA segments with restriction enzymes, determining the molecular masses of the restriction fragments and comparing the molecular masses with the molecular masses of theoretical restriction digests of known mitochondrial DNA sequences stored in a database. | 05-14-2009 |
20090239224 | Methods for identifying bioagents - The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases. | 09-24-2009 |
20100145626 | Systems for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy - The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases. | 06-10-2010 |
20130337452 | Methods For Rapid Forensic Analysis Of Mitochondrial DNA - The present invention provides methods for rapid forensic analysis of mitochondrial DNA by amplification of a segment of mitochondrial DNA containing restriction sites, digesting the mitochondrial DNA segments with restriction enzymes, determining the molecular masses of the restriction fragments and comparing the molecular masses with the molecular masses of theoretical restriction digests of known mitochondrial DNA sequences stored in a database. | 12-19-2013 |
20150031117 | METHODS FOR RAPID FORENSIC ANALYSIS OF MITOCHONDRIAL DNA AND CHARACTERIZATION OF MITOCHONDRIAL DNA HETEROPLASMY - The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases. | 01-29-2015 |